MDLinxLots of Celebrities Take This Common Heart Drug—But Not for What You Think

🎓 Expert Commentary / Peer Perspective

Beta blockers have been used off-label for performance anxiety for decades, working by blunting adrenergic symptoms rather than addressing cognitive anxiety pathways. Increased celebrity disclosure is generating patient awareness and inquiries, making this a timely patient counseling topic for primary care and internal medicine physicians.

Patient Counseling Points

• Beta blockers reduce physical anxiety symptoms (tachycardia, tremor, diaphoresis) by blocking adrenaline; they do not address the cognitive or psychological root of anxiety
• They are not addictive and do not cause sedation, distinguishing them from benzodiazepines in the risk profile conversation
• Contraindications include low blood pressure, bradycardia, asthma, and heart failure; fatigue, dizziness, and nausea are common side effects to monitor
• Evidence supports use for performance anxiety; beta blockers are not a first-line or well-validated option for generalized anxiety disorder

Patient Care Applications

• Recognize that celebrity coverage is driving patient requests; prepare a clear, balanced response that neither dismisses nor overclaims
• Redirect patients with generalized anxiety toward established first-line treatments including SSRIs and CBT
• Warn patients that beta blockers treat symptoms, not underlying anxiety mechanisms, and work best as an adjunct to therapy
• Avoid prescribing in patients with contraindicated cardiac or respiratory histories regardless of low perceived addiction risk